U.S. Markets close in 1 hr 49 mins

MannKind Corporation (MNKD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.0900+0.1400 (+4.75%)
As of 11:11AM EST. Market open.

MannKind Corporation

30930 Russell Ranch Road
Suite 300
Westlake Village, CA 91362
United States
818 661 5000
http://www.mannkindcorp.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees232

Key Executives

NameTitlePayExercisedYear Born
Dr. Michael E. CastagnaCEO & Director844.2kN/A1977
Mr. Steven B. BinderChief Financial Officer630.4kN/A1963
Dr. David B. ThomsonCorp. VP, Gen. Counsel & Sec.675.97kN/A1967
Mr. James Patrick McCauley Jr., J.D., M.B.A.Chief Commercial Officer614.06kN/A1966
Mr. Joseph KocinskyChief Technology OfficerN/AN/A1964
Ms. Rosabel Realica AlinayaVP of Investor Relations & TreasuryN/AN/A1961
Dr. Stuart A. TrossChief People & Workplace OfficerN/AN/A1967
Mr. John F. BedardSr. VP of Worldwide Regulatory AffairsN/AN/A1950
Mr. Alejandro Galindo M.B.A., M.S.Chief Commercial OfficerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of treprostinil used for the treatment of pulmonary arterial hypertension. MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, California.

Corporate Governance

MannKind Corporation’s ISS Governance QualityScore as of November 1, 2019 is 8. The pillar scores are Audit: 5; Board: 7; Shareholder Rights: 4; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.